Product Code: GVR-4-68038-193-1
Sterile Tubing Welder Market Growth & Trends:
The global sterile tubing welder market size is expected to reach USD 3.46 billion by 2030, registering a CAGR of 5.2% from 2023 to 2030, according to a new report by Grand View Research, Inc. Increasing demand for blood, blood products, and biopharmaceutical products is anticipated to drive the market for sterile tubing welder.
Blood transfusion is one of the frequently performed medical procedures. Severe road traffic injuries, major surgical procedures, and hematology diseases, such as thalassemia, anemia, and leukemia, are some of the key reasons for the transfusion procedure. According to the Association for Safe International Road Travel (ASIRT) article, nearly 20 to 50 million individuals are injured or disabled in road accidents. Thus, high cases of road traffic injuries are anticipated to fuel sterile tubing welder market growth.
Wastage of collected blood due to contamination, blood bag leakages, improper storage, and lack of proper handling facilities and qualified professionals are anticipated to increase the demand for innovative and medically advanced sterile instruments, such as automated sterile tubing welders. For instance, in India, nearly 10% of blood components and around 71% of whole blood are wasted each year due to the above-stated reasons.
Sterile Tubing Welder Market Report Highlights:
- Based on mode, the automatic segment held the largest market share of over 80% in 2022and is anticipated to witness the highest growth over the forecast period due to ease of operation and reduced labor costs
- On the basis of application, the blood processing segment held the largest revenue share of over 60% in 2022 due to a large number of patients being treated using apheresis annually across the globe
- By end-use, the hospitals segment accounted for the largest revenue share of over 40% in 2022 owing to rise in the adoption of advanced instruments and enhanced services in these settings
- North America dominated the market and accounted for the largest revenue share of over 35% in 2022. This can be attributed to the presence of numerous biopharmaceutical companies and high demand for biopharmaceutical products
- The Asia Pacific region is expected to grow at the fastest CAGR of 5.8% during the forecast period due to a large number of clinical trials being conducted and rise in the number of medical device companies in the region
- Mergers & acquisitions are the key strategies adopted by the market players
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.1.1. Application
- 1.1.2. Mode
- 1.1.3. End use
- 1.1.4. Regional scope
- 1.1.5. Estimates and forecast timeline
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
- 1.4. Information or Data Analysis
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.7. List of Secondary Sources
- 1.8. List of Primary Sources
- 1.9. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Application
- 2.2.2. Mode
- 2.2.3. End use
- 2.2.4. Regional scope
- 2.3. Competitive Insights
Chapter 3. Sterile Tubing Welder Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Penetration & Growth Prospect Mapping
- 3.3. Market Dynamics
- 3.3.1. Market driver analysis
- 3.3.2. Market restraint analysis
- 3.4. Sterile Tubing Welder Market Analysis Tools
- 3.4.1. Industry Analysis - Porter's
- 3.4.1.1. Supplier power
- 3.4.1.2. Buyer power
- 3.4.1.3. Substitution threat
- 3.4.1.4. Threat of new entrant
- 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL Analysis
- 3.4.2.1. Political landscape
- 3.4.2.2. Technological landscape
- 3.4.2.3. Economic landscape
Chapter 4. Sterile Tubing Welder Market: Application Estimates & Trend Analysis
- 4.1. Sterile Tubing Welder Market: Key Takeaways
- 4.2. Sterile Tubing Welder Market: Movement & Market Share Analysis, 2022 & 2030
- 4.3. Biopharmaceutical
- 4.3.1. Biopharmaceutical market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.4. Blood Processing
- 4.4.1. Blood processing market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.5. Diagnostic Laboratories
- 4.5.1. Diagnostics laboratories market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.6. Others
- 4.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Sterile Tubing Welder Market: Mode Estimates & Trend Analysis
- 5.1. Sterile Tubing Welder Market: Key Takeaways
- 5.2. Sterile Tubing Welder Market: Movement & Market Share Analysis, 2022 & 2030
- 5.3. Manual
- 5.3.1. Manual market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.4. Automatic
- 5.4.1. Automatic market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Sterile Tubing Welder Market: End Use Estimates & Trend Analysis
- 6.1. Sterile Tubing Welder Market: Key Takeaways
- 6.2. Sterile Tubing Welder Market: Movement & Market Share Analysis, 2022 & 2030
- 6.3. Hospitals
- 6.3.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
- 6.4. Research Clinics
- 6.4.1. Research clinics market estimates and forecasts, 2018 to 2030 (USD Million)
- 6.5. Blood Centers
- 6.5.1. Blood centers market estimates and forecasts, 2018 to 2030 (USD Million)
- 6.6. Others
- 6.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 7. Sterile Tubing Welder Market: Regional Estimates & Trend Analysis
- 7.1. Regional Outlook
- 7.2. Sterile Tubing Welder Market by Region: Key Marketplace Takeaway
- 7.3. North America
- 7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.3.2. U.S.
- 7.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.3.3. Canada
- 7.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4. Europe
- 7.4.1. UK
- 7.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.2. Germany
- 7.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.3. France
- 7.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.4. Italy
- 7.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.5. Spain
- 7.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.6. Sweden
- 7.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.7. Norway
- 7.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.4.8. Denmark
- 7.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.5. Asia Pacific
- 7.5.1. Japan
- 7.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.5.2. China
- 7.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.5.3. India
- 7.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.5.4. Australia
- 7.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.5.5. Thailand
- 7.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.5.6. South Korea
- 7.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.6. Latin America
- 7.6.1. Brazil
- 7.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.6.2. Mexico
- 7.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.6.3. Argentina
- 7.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.7. MEA
- 7.7.1. Saudi Arabia
- 7.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.7.2. South Africa
- 7.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.7.3. UAE
- 7.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 7.7.4. Kuwait
- 7.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Chapter 8. Competitive Landscape
- 8.1. Recent Developments & Impact Analysis, By Key Market Participants
- 8.2. Market Participant Categorization
- 8.2.1. Sartorius AG
- 8.2.1.1. Company overview
- 8.2.1.2. Financial performance
- 8.2.1.3. Product benchmarking
- 8.2.1.4. Strategic initiatives
- 8.2.2. Terumo BCT, Inc.
- 8.2.2.1. Company overview
- 8.2.2.2. Financial performance
- 8.2.2.3. Product benchmarking
- 8.2.2.4. Strategic initiatives
- 8.2.3. GE Healthcare
- 8.2.3.1. Company overview
- 8.2.3.2. Financial performance
- 8.2.3.3. Product benchmarking
- 8.2.3.4. Strategic initiatives
- 8.2.4. MGA Technologies
- 8.2.4.1. Company overview
- 8.2.4.2. Financial performance
- 8.2.4.3. Product benchmarking
- 8.2.4.4. Strategic initiatives
- 8.2.5. Vante Biopharm / Sebra.
- 8.2.5.1. Company overview
- 8.2.5.2. Financial performance
- 8.2.5.3. Product benchmarking
- 8.2.5.4. Strategic initiatives
- 8.2.6. Genesis BPS
- 8.2.6.1. Company overview
- 8.2.6.2. Financial performance
- 8.2.6.3. Product benchmarking
- 8.2.6.4. Strategic initiatives
- 8.2.7. Biomen Biosystems Co., Ltd.
- 8.2.7.1. Company overview
- 8.2.7.2. Financial performance
- 8.2.7.3. Product benchmarking
- 8.2.7.4. Strategic initiatives
- 8.2.8. SynGen, Inc.
- 8.2.8.1. Company overview
- 8.2.8.2. Financial performance
- 8.2.8.3. Product benchmarking
- 8.2.8.4. Strategic initiatives
- 8.2.9. Sentinel Process Systems, Inc.
- 8.2.9.1. Company overview
- 8.2.9.2. Financial performance
- 8.2.9.3. Product benchmarking
- 8.2.9.4. Strategic initiatives
- 8.2.10. Flex Concepts, Inc.
- 8.2.10.1. Company overview
- 8.2.10.2. Financial performance
- 8.2.10.3. Product benchmarking
- 8.2.10.4. Strategic initiatives
- 8.2.11. Shanghai Le Pure Biological Technology Co., Ltd.
- 8.2.11.1. Company overview
- 8.2.11.2. Financial performance
- 8.2.11.3. Product benchmarking
- 8.2.11.4. Strategic initiatives